Previous studies found that inhibition of GLP-1 and GIP levels by octreotide can also improve dumping syndrome.[14] Therefore, the detection of GLP-1 and GIP may further indicate the mechanism of beinaglutide in the treatment of dumping syndrome. This evidence concerns the gene GIP and dumping syndrome.